🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David C. Fisher

Dana-Farber Cancer Institute

ORCID: 0000-0001-6915-8584
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.518Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574
Top 37%
0.518DataRank
Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

Papers

Driven by 15 papers — median percentile 63. Top paper: “Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study”.

Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00455-1
N/A
3.3DataRank · unranked
104 citations

Benjamin L. Lampson, Svitlana Tyekucheva, Zixu Wang, Jessica Lowney, Samantha Pazienza +13 more

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Blood Advances(2020)10.1182/bloodadvances.2019000784
N/A
2.0DataRank · unranked
65 citations

Philippe Armand, Robert Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman +21 more

Venetoclax plus dose-adjusted R-EPOCH for Richter syndrome

Blood(2022)10.1182/blood.2021011386
N/A
0.650DataRank · unranked
75 citations

Kerry A. Rogers, Svitlana Tyekucheva, Zixu Wang, Samantha Pazienza, Sarah K. Renner +10 more

Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.10.010
N/A
0.618DataRank · unranked
17 citations

Robert Redd, Erin Jeter, Jeff L. Wong, Kristin M McHugh, Carol Reynolds +21 more

A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma

Blood(2023)10.1182/blood.2023020244
N/A
0.598DataRank · unranked
15 citations

Parastoo B. Dahi, Robert Redd, Mikaela M. McDonough, Yi‐Bin Chen, Zachariah DeFilipp +15 more

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

Blood Advances(2024)10.1182/bloodadvances.2023011574
Top 37%
0.518DataRank
Top 37%12 citations

Danielle M. Brander, Yue Ren, Yinglu Zhou, Svitlana Tyekucheva, Heather A. Walker +18 more

Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

American Journal of Hematology(2020)10.1002/ajh.26084
N/A
0.510DataRank · unranked
29 citations

Sarah R. Walker, Lisa N. Heppler, Svitlana Tyekucheva, Erik A. Nelson, Josephine L. Klitgaard +15 more

A T cell inflammatory phenotype is associated with autoimmune toxicity of the PI3K inhibitor duvelisib in chronic lymphocytic leukemia

Leukemia(2021)10.1038/s41375-021-01441-9
N/A
0.464DataRank · unranked
21 citations

Alec Griffith, Svitlana Tyekucheva, Zixu Wang, Vanessa Rai, Alexander R. Vartanov +14 more

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016006
N/A
0.385DataRank · unranked
12 citations

Yinglu Zhou, Mariia Mikhaleva, Daniel Choi, Stacey M. Fernandes, Philippe Armand +20 more

Circulating Th17 T cells at treatment onset predict autoimmune toxicity of PI3Kδ inhibitors

Blood Cancer Journal(2023)10.1038/s41408-023-00788-9
N/A
0.208DataRank · unranked
3 citations

Stephen P. Martindale, Pui Yan Chiu, Jasneet Kaur Khalsa, Pei-Hsuan Chen, Stacey M. Fernandes +10 more

SAVE (Safe Accelerated Venetoclax Escalation): Initial results of a prospective, phase Ib study of venetoclax with an accelerated dose ramp-up in patients with CLL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7512
N/A
0.165DataRank · unranked
2 citations

Inhye E. Ahn, Svitlana Tyekucheva, Reid W. Merryman, David C. Fisher, Philippe Armand +7 more

Data from Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6518805.v1
N/A
0DataRank · unranked
0 citations

Eyal C. Attar, Tak Takvorian, Ephraim P. Hochberg, Karen K. Ballen, K. Leahy +9 more

Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management

Dermatology and Therapy(2021)10.1007/s13555-021-00624-7
N/A
0DataRank · unranked
44 citations

Kerri E. Rieger, M. Bagot, Jennifer Choi, David C. Fisher, Joan Guitart +11 more

Long‐term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia

HemaSphere(2025)10.1002/hem3.70067
N/A
0DataRank · unranked
0 citations

Yue Ren, Svitlana Tyekucheva, Jon Arnason, Adam Boruchov, Caron A. Jacobson +6 more

Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement

British Journal of Haematology(2023)10.1111/bjh.19037
N/A
0DataRank · unranked
16 citations

Rebecca L. Zon, Robert Redd, David C. Fisher, Roni Shouval, Anita Kumar +12 more